Literature DB >> 15773892

Human Rad9 is required for the activation of S-phase checkpoint and the maintenance of chromosomal stability.

Tongyun Dang1, Shideng Bao, Xiao-Fan Wang.   

Abstract

In response to DNA damage or replication block, cells activate a battery of checkpoint signaling cascades to control cell cycle progression and elicit DNA repair in order to maintain genomic stability and integrity. Identified as a homolog of its fission yeast counterpart, human Rad9 was proposed to form a Rad9-Hus1-Rad1 protein complex to mediate checkpoint signals. However, the precise function of Rad9 in the process of checkpoint activation is not fully understood. Using the RNA interference technique, we investigated the role of Rad9 in the genotoxic stress-induced activation of S-phase checkpoint and the maintenance of chromosomal stability. We found that Rad9 knockdown reduced the phosphorylation of Rad17, Chk1 and Smc1 in response to DNA replication block and certain types of DNA damage. Immunofluorescence studies showed that the removal of Rad9 disrupted the foci formation of phosphorylated Chk1, but not ATR. Moreover, Rad9 knockdown resulted in radioresistant DNA synthesis and reduced cell viability under replication stress. Finally, removal of Rad9 by RNAi led to increased accumulation of spontaneous chromosomal aberrations. Taken together, these results suggest a critical and specific role of Rad9 in the activation of S-phase checkpoint and the maintenance of chromosome stability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15773892     DOI: 10.1111/j.1365-2443.2005.00840.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  16 in total

Review 1.  The role of RAD9 in tumorigenesis.

Authors:  Howard B Lieberman; Joshua D Bernstock; Constantinos G Broustas; Kevin M Hopkins; Corinne Leloup; Aiping Zhu
Journal:  J Mol Cell Biol       Date:  2011-02       Impact factor: 6.216

2.  Specific role of Chk1 phosphorylations in cell survival and checkpoint activation.

Authors:  Hiroyuki Niida; Yuko Katsuno; Birendranath Banerjee; M Prakash Hande; Makoto Nakanishi
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

3.  Cross-talk between Chk1 and Chk2 in double-mutant thymocytes.

Authors:  Kathrin Zaugg; Yu-Wen Su; Patrick T Reilly; Yasmin Moolani; Carol C Cheung; Razquallah Hakem; Atsushi Hirao; Qinghua Liu; Stephen J Elledge; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-26       Impact factor: 11.205

4.  Jab1 mediates protein degradation of the Rad9-Rad1-Hus1 checkpoint complex.

Authors:  Jin Huang; Honglin Yuan; Chongyuan Lu; Ximeng Liu; Xu Cao; Mei Wan
Journal:  J Mol Biol       Date:  2007-06-04       Impact factor: 5.469

5.  Loss of Hus1 sensitizes cells to etoposide-induced apoptosis by regulating BH3-only proteins.

Authors:  C L Meyerkord; Y Takahashi; R Araya; N Takada; R S Weiss; H-G Wang
Journal:  Oncogene       Date:  2008-09-15       Impact factor: 9.867

Review 6.  Replication fork recovery and regulation of common fragile sites stability.

Authors:  Annapaola Franchitto; Pietro Pichierri
Journal:  Cell Mol Life Sci       Date:  2014-09-13       Impact factor: 9.261

7.  RAD9 enhances radioresistance of human prostate cancer cells through regulation of ITGB1 protein levels.

Authors:  Constantinos G Broustas; Howard B Lieberman
Journal:  Prostate       Date:  2014-08-11       Impact factor: 4.104

8.  Rad9a is involved in chromatin decondensation and post-zygotic embryo development in mice.

Authors:  Lin Huang; Tie-Gang Meng; Xue-Shan Ma; Zhen-Bo Wang; Shu-Tao Qi; Qi Chen; Qing-Hua Zhang; Qiu-Xia Liang; Zhong-Wei Wang; Meng-Wen Hu; Lei Guo; Ying-Chun Ouyang; Yi Hou; Yong Zhao; Qing-Yuan Sun
Journal:  Cell Death Differ       Date:  2018-08-28       Impact factor: 15.828

9.  Prostate cancer: unmet clinical needs and RAD9 as a candidate biomarker for patient management.

Authors:  Howard B Lieberman; Alex J Rai; Richard A Friedman; Kevin M Hopkins; Constantinos G Broustas
Journal:  Transl Cancer Res       Date:  2018-01-14       Impact factor: 1.241

10.  Targeted deletion of Rad9 in mouse skin keratinocytes enhances genotoxin-induced tumor development.

Authors:  Zhishang Hu; Yuheng Liu; Chunbo Zhang; Yun Zhao; Wei He; Lu Han; Leilei Yang; Kevin M Hopkins; Xiao Yang; Howard B Lieberman; Haiying Hang
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.